SCHEMBL17437312

SCHEMBL17437312

Nc1ncnn1-c1nc2cncc(-c3ccccc3F)c2n1C1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAPK8 P45983 7/20 0.34
▸ MAPK9 P45984 7/20 0.34
▸ MAPK10 P53779 7/20 0.34
▸ MAPK14 Q16539 5/20 0.34
▸ CYP11B1 P15538 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ ADORA3 P0DMS8 2/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ AURKA O14965 2/20 0.32
▸ JAK2 O60674 2/20 0.32
▸ PRKCA P17252 2/20 0.32
▸ JAK1 P23458 2/20 0.32
▸ KDR P35968 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ADORA2B P29275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437529 0.95 CYP11B2 (0.37) ALDH1A1CYP11B1CYP11B2ALOX15RXFP1
SCHEMBL17437480 0.89 KDM4E (0.34) KDM4EALDH1A1MAPK1ADORA3ADORA2A
SCHEMBL17437486 0.84 SLC9A1 (0.33) ALDH1A1CYP11B1CYP11B2ALOX15
SCHEMBL17437381 0.82 CRHR1 (0.35) ALDH1A1ADORA3ADORA2AADORA1MEN1
SCHEMBL17437313 0.81 MAPT (0.34) KDM4EALDH1A1MAPK1ADORA2AMEN1
SCHEMBL17437512 0.80 CYP11B2 (0.34) CYP11B2ADORA2A
SCHEMBL17437327 0.80 ADORA3 (0.39) ADORA3ADORA2AADORA1AURKAJAK2
SCHEMBL17437460 0.78 RPS6KA5 (0.34) ADORA2A
SCHEMBL17437316 0.78 KDM4E (0.36) KDM4EALDH1A1MAPK1CYP11B1CYP11B2
SCHEMBL17437394 0.77 CYP1A2 (0.33) CYP11B1CYP11B2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 KDM4E 1452/4885ALDH1A1 928/4885MAPK1 1737/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 KDM4E 1452/4885ALDH1A1 928/4885MAPK1 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback